Cyberounds Logo
September 26, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Development of Guidelines for the Use of Orexigenic Drugs in Long-Term Care
CME credit is no longer available for this conference.
John E. Morley, M.D., and David R. Thomas, M.D.

Dr. Thomas is Professor of Medicine, St. Louis University School of Medicine.

During the last three years, Dr. Morley has received grant/research support from Vivus, Merck & Co., Pharmacia, B. Braun McGaw, Bayer Corp and Nestec, Ltd. He has also served on the Speakers' Bureau for LXN, Organon, Ross, Pharmacia, GlaxoSmithKline, Aventis, Searle, Merck & Co., Roche, Bristol-Myers Squibb, Novartis, Pratt, B.Braun McGaw, Pfizer and Solvay. During the last three years, Dr. Thomas has received grant/research support from Nestle.

This Cyberounds® is published simultaneously in the Supplement to the June 2003 issue of Annals of Long-Term Care, in cooperation with the Council for Nutritional Clinical Strategies in Long-Term Care, which received an unrestricted educational grant from Solvay Pharmaceuticals, Inc.

Release Date: 06/24/2003
Termination Date: 06/24/2006

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Evaluate outcomes of undernutrition in long-term care
  • Describe interventions for undernutrition in long-term care
  • Discuss options for use of orexigenic agents.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity